Future of Health Data Summit

How AI and new technology will transform healthcare for everyone from Patients to Providers to Researchers and Regulators

Value-Based Care has had many forms and names, arguably over the past two the three decades. Over that period of time, regulatory changes helped to shape what appears to be a more sustainable model – we will discuss the current state of affairs, and what will be necessary to support VBC (or a newly named iteration) success over the long run. Notably, we will focus on what payers and the broader healthcare ecosystem learned via the market “reset” over the past two years, and the how data liquidity and scaled AI can help to ensure this success.

This panel will explore the friction between data protection and data use and discuss how stakeholders balance privacy and progress in healthcare innovation. Our discussion will examine:
How evolving AI models amplify both the promise and the risks of healthcare data use
Where privacy law, ethical frameworks, and real-world practices align—or conflict
How “de-identification” and “consent” play out as guardrails in a world of health AI, analytics, and seemingly infinite data use initiatives
Practical approaches to balance compliance, trust, and innovation in health data ecosystems

Bringing together leaders at the forefront of research, clinical practice, and lived experience to explore the role of psychedelics in treating mental health conditions.
In this discussion, Marcus Capone of TARA Mind, Dr. Brandan Weiss of Johns Hopkins, Dr. Dan Karlin of MindMed, and TBD will share diverse perspectives on the science, practice, and future of psychedelic-assisted therapies. Together, they will examine emerging evidence, clinical applications, and the challenges of integrating these treatments into mainstream medicine.

Healthcare organizations are facing mounting pressures—rising administrative costs, workforce shortages, and growing demands for interoperability. Too often, these challenges burden providers, payers, and patients alike, straining resources and slowing innovation.
This session explores how digital automation is transforming these burdens into breakthroughs. From unlocking value with automated data exchange to reducing manual processes and improving data accuracy, digital tools are creating new efficiencies and unlocking value across the healthcare ecosystem. These innovations streamline workflows, support compliance, and ultimately enhance patient outcomes.
Attendees will gain insights into real-world use cases, learn how leading organizations are deploying automation at scale, and discover practical strategies to maximize impact while maintaining quality of care.

The healthcare industry is at a critical inflection point, where access to capital and strategic investment decisions can unlock meaningful transformation. This panel brings together leading investors to explore how funding trends are shaping the healthcare landscape and the ways in which capital deployment can accelerate innovation.

AI is set to reshape how we think about everything, from business insights to how we interface with our wearable devices. In this session, we’ll hear from technologists and government officials who will share their perspectives on how AI has been built into their products, the safeguards and frameworks they leveraged to get to market, how to make sense of the data and how the data behind AI is being protected.

How do we earn and keep patient trust in a world where data is constantly shared and analyzed? This session brings together leaders from life sciences, providers, and payers to explore what transparency really looks like in practice. From consent models and privacy-preserving technologies to clear communication and responsible data use, we’ll unpack the strategies that build confidence and protect the patient relationship.